Alvogen - Business Information

Q: What industry does Alvogen belong to?

Alvogen is in the industry of: Pharmaceuticals , Healthcare

Manufacturing · New Jersey, United States · 2,400 Employees

Alvogen, founded in 2009 headquartered in Morristown, New Jersey, operates as a pharmaceutical company. The Company develops, manufactures, and markets parallel imported and generic drugs. Alvogen Pharma US serves clients worldwide.Read More

View Company Info for Free

Who is Alvogen

Headquarters

10 Bloomfield Ave, Pine Brook, New Jersey, 07058, United States

Phone Number

(973) 796-3400

Website

www.alvogen.com

Revenue

$717.6M

Industry

Pharmaceuticals

Healthcare

Is this data correct?

View contact profiles from Alvogen

Popular SearchesAlvogenalvogen IncNorwich Pharmaceuticals IncAlvogen Group IncNorwich PharmaceuticalsSIC Code 28,283NAICS Code 32,325Show More

Top Competitors of Alvogen

Amneal Pharmaceuticals Inc
7,000
$2.1B
1
Synthon Pharmaceuticals Inc
1,721
$273.7M
2
Lannett Co Inc
810
$372.4M
3
Par Pharmaceutical Companies I...
1,758
$238.6M
4
Bausch Health Companies Inc
19,600
$8.3B
5
Cambrex Corp
2,400
$717.6M
6

Alvogen Org Chart

View Alvogen org chart to access information on key employees and get valuable insights about Alvogen organizational structure. The organizational chart highlights the reporting lines within the company, starting with Justin Lee - the Chief Executive Officer At Alvogen Korea of Alvogen, and followed by additional decision makers: Nilesh Bhanage, Director - Chief Marketing Officer Management ( External Manufacturing Operation ), and Tunie Zaku, Chief Financial Officer (US).

Justin Lee

Chief Executive Officer At A...

Phone

Nilesh Bhanage

Director - Chief Marketing O...

Phone

Tunie Zaku

Chief Financial Officer (US)

Phone

View Email Formats for Alvogen

Alvogen Company Metrics

Company Insights

Employee Growth Rate

Funding

Funding DateJun 30, 2021

RoundStock Issuance/Offering

Amount$100M

InvestorsAztiq Pharma Partners

$100M

Total Funding Amount

$100M

Most Recent Funding Amount

Number of Funding Rounds

Acquisitions & Subsidiaries

Jul 18, 2022

AlvogenUS

Jul 18, 2022

Zentiva.co.uk

Oct 27, 2018

Omega Bittner

Sep 20, 2018

SICOmed

Feb 02, 2016

Labormed Pharma

Apr 06, 2015

Lotus Pharmaceutical

See More Acquisitions & Subsidiaries

Alvogen Tech Stack

Microsoft Excel

Microsoft

Daily

The Daily.co.uk

eSSential

eLogic Learning

Alteryx

See more technologies

Top Companies in United States

View leading companies in United States by different categories: revenue, number of employees and funding amount. Top companies in United States by revenue is Walmart, by number of employees is Tip Top Poultry and by funding amount is American Airlines. See full lists for all leading companies and additional company information such as contact details, org chart, industry, employees and more.

Alvogen News & Media

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Announce Collaboration
RADNOR, Pa. and MORRISTOWN, N.J. and TAIPEI, Taiwan, June 05, 2023 (GLOBE NEWSWIRE) — Lotus Pharmaceuticals, a multinational pharmaceutical company,... Read More The post NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Announce Collaboration appeared first on citybiz.
Jun 5, 2023
www.citybiz.co
NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101
RADNOR, Pa. and MORRISTOWN, N.J. and TAIPEI, Taiwan, June 05, 2023 (GLOBE NEWSWIRE) -- Lotus Pharmaceuticals (1795:TT; “Lotus”), a multinational pharmaceutical company, Alvogen, a privately owned U.S. based pharmaceuticals company, and NRx Pharmaceuticals Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals or NRx”), a clinical stage biopharmaceutical company, today announced a global collaboration agreement covering the development and commercialization of NRX-101 for suicidal treatment-resistant bipolar
Jun 5, 2023
www.globenewswire.com
Privately Held Alvogen Announces Favorable Ruling on Patents Related to the Company’s Proposed Generic to Xifaxan® for IBS-D
MORRISTOWN, N.J.--(BUSINESS WIRE)--Alvogen, a privately held pharmaceutical company focused on developing, manufacturing and selling generic and branded products, announced today a favorable district court ruling on multiple patents related to the company’s proposed generic to Xifaxan®, a treatment for irritable bowel syndrome with diarrhea (IBS-D) in adults. “We are extremely pleased with the district court’s decision, which brings us one step closer to bringing a more affordable alternative t
Aug 11, 2022
www.businesswire.com
PTT raises stake in Taiwan firm - The Bangkok Post
National oil and gas conglomerate PTT has taken a significant step into the pharmaceutical sector by teaming up with the Aztiq Fund to buy out Alvogen Emerging Markets Holdings (AEMH), increasing PTT's shareholding in Taiwan-based Lotus Pharmaceutical Co to 37% from 6.6%.
Nov 28, 2021
www.bangkokpost.com
Aztiq Buys 17% Stake in Alvogen US
REYKJAVIK, Iceland--(BUSINESS WIRE)--Aztiq Pharma Partners, a private equity fund led by Róbert Wessman, today announced that it has completed a US$100 million financing to purchase a newly issued share equity in Alvogen US. Morgan Stanley led the financing, which was subscribed by international institutional investors. The capital was used by Aztiq to buy a 17% stake in Alvogen US, at Fora pre-money valuation of US$ 350 million. “The new equity will allow Alvogen's generic business
Jun 30, 2021
www.businesswire.com